CORRECTION: Wells Fargo On Mar. 4 Lowered Gilead PT From $84 To $78
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Mohit Bansal has maintained an Equal-Weight rating on Gilead Sciences (NASDAQ:GILD) and lowered the price target from $84 to $78 on March 4.
April 03, 2024 | 3:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wells Fargo maintained an Equal-Weight rating on Gilead Sciences and lowered the price target from $84 to $78.
The reduction in the price target by Wells Fargo suggests a more cautious outlook on Gilead Sciences' future stock performance. This adjustment could lead to a negative short-term impact on GILD's stock price as investors recalibrate their expectations based on this new analyst assessment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100